Newron Pharmaceuticals SpA

FSX:NP5.DE

10.24 (EUR) • At close June 14, 2024
Bedrijfsnaam Newron Pharmaceuticals SpA
Symbool NP5.DE
Munteenheid EUR
Prijs 10.24
Beurswaarde 190,789,632
Dividendpercentage 0%
52-weken bereik 4.24 - 12
Industrie Pharmaceuticals, Biotechnology & Life Sciences
Sector Healthcare
CEO Prof. Stefan Weber
Website https://www.newron.com/

An error occurred while fetching data.

Over Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. The company is headquartered in Bresso, Milano and currently employs 24 full-time employees. The company focuses on the discovery and development of pharmaceutical products. The firm is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS)

Vergelijkbare Aandelen

PharmaSGP Holding SE logo

PharmaSGP Holding SE

PSG.DE

22.6 EUR

Tilray Brands, Inc. logo

Tilray Brands, Inc.

2HQ.DE

1.696 EUR

Dermapharm Holding SE logo

Dermapharm Holding SE

DMP.DE

36.3 EUR

Bayer Aktiengesellschaft logo

Bayer Aktiengesellschaft

BAYN.DE

27.065 EUR

MERCK Kommanditgesellschaft auf Aktien logo

MERCK Kommanditgesellschaft auf Aktien

MRK.DE

172 EUR

Zoetis Inc. logo

Zoetis Inc.

ZOE.DE

156.35 EUR

Sanofi logo

Sanofi

SNW.DE

101 EUR

AstraZeneca PLC logo

AstraZeneca PLC

ZEG.DE

120.9 EUR

Bristol-Myers Squibb Company logo

Bristol-Myers Squibb Company

BRM.DE

53.5 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)